George R. Parker

Alabama State Bar, President’s Award, 2020 American Bar Foundation, Fellow Listed in The Best Lawyers in America® "Lawyer of the Year," Montgomery, Litigation – Insurance, 2022, 2024 "Lawyer of the Year," Montgomery, Product Liability Litigation – Defendants, 2021 Commercial Litigation, 2015-2025 Litigation – Insurance, 2015-2025 Product Liability Litigation – Defendants, 2016-2025 Listed in Mid-South Super Lawyers, General Litigation, 2016-2018, 2023 Listed in Alabama Super Lawyers, General Litigation, 2013-2015 Martindale-Hubbell® AV Preeminent Rated 2009 ABA TIPS NOW Fellows Selection, 2009-2011 Alabama State Bar Leadership Forum Selection, 2007  Alabama Access to Justice Commission, Pro Bono Exemplar, 2015 PPA products liability litigation Represented Bayer in national litigation concerning phenylpropanolamine. Took numerous depositions of plaintiffs and treating physicians in PPA litigation. HRT litigation Served as regional counsel team deposing plaintiffs and treating physicians throughout the USA.  Ex Parte Clarksville Refrigerated Lines I, LTD, 2003 WL 1900701 (Ala. 2003) In Re: Yasmin and YAZ (Drospirenone) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2100 (S.D. Illinois) National team member for Bayer. Revells v. Metropolitan Life Ins. Co., 261 F. Supp. 2d 1359 (M.D. Ala. 2003) Granting summary judgment and holding that bad faith claim was not saved from ERISA preemption and that offsets for Social Security payments did not violate Social Security Act. USA Petroleum Corp. v. Hines, 770 So2d 589 (Ala. 1999) Reglan/Metoclopramide litigation for Pfizer Inc. (national team) Serve on the national counsel team for Pfizer Inc. in litigation over Reglan/Metoclopramide, which involves approximately 6,300 plaintiffs in various cases in venues across the country. There is no MDL, but there are coordinated proceedings in Pennsylvania, California, and New Jersey, and several single-plaintiff and mass-plaintiff actions pending in state and federal courts in other jurisdictions.